Orforglipron is beneficial for blood glucose control in individuals with type 2 diabetes using metformin or taking insulin glargine, according to two studies published online June 8 in The Lancet and the JAMA to coincide with the annual meeting of the American Diabetes Association, held from June 5 to 8 in New Orleans.
